EGFR and neoplasm: To compare the cellular landscape between two different molecular subtypes of lung cancer based on the EGFR mutation status, we prepared tumor specimens surgically resected from 10 patients with NSCLC in stages IA–IIIA: five EGFR-WT and five EGFR-MT (Supplementary Data 1).